Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
Simona Cernea, Danusia Onișor
Abstract
) and pharmacological interventions that might play a protective role by targeting the underlying causative factors and pathogenetic mechanisms. However, well-designed prospective studies specifically dedicated to NAFLD/NASH patients are still needed to clarify the relationship with HCC risk.
Topics & Concepts
MedicineHepatocellular carcinomaCirrhosisNonalcoholic fatty liver diseaseSteatohepatitisInternal medicineFatty liverContext (archaeology)Viral hepatitisHepatitis BGastroenterologyLiver cancerInsulin resistanceLiver diseaseHepatitis CDiseaseObesityPaleontologyBiologyLiver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisHepatitis C virus research